A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease
A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease
Recruiting · NCT07536061 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease | Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Huntington disease, basal ganglia disorder, brain disorder, central nervous system disorder, choreatic disease, cognitive disorder, dementia, hereditary disease, inherited neurodegenerative disorder, movement disorder, nervous system disorder, neurodegenerative disease, psychiatric disorder | Recruiting | Phase 1 | 2026-09-04 | NCT07536061 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sarepta Therapeutics, Inc. | 15 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| New Zealand Brain Research Institute | Christchurch | New Zealand | 1 |
| Siloah AG | Gümligen | Switzerland | 1 |
| University Hospital of Wales | Cardiff | United Kingdom | 1 |
| Westmead Hospital | Westmead | Australia | 128 |